Epidemiology of Colorectal Cancer in Inflammatory Bowel Disease – the Evolving Landscape

Elyse A. Linson*, Stephen B. Hanauer

*Corresponding author for this work

Research output: Contribution to journalReview articlepeer-review

9 Scopus citations


Purpose of Review: To update changes in the epidemiology of colorectal cancer in patients with ulcerative colitis and Crohn’s disease over the past decades. Recent Findings: Since the mid twentieth century, studies have found that the incidence of colorectal cancer in patients with IBD has been greater than that of the general population, especially for patients with a family history of colorectal cancer, a diagnosis of primary sclerosing cholangitis, and/or pancolitis. While Crohn’s disease and ulcerative colitis are still associated with a risk of colorectal cancer, current treatment approaches and surveillance measures have markedly reduced the risk according to population-based cohort studies such that the risk is now more comparable to that of the general population. Summary: It is predicted that by 2025, more than two million patients will be living with inflammatory bowel disease in the United States. As advanced treatment options become available to achieve histologic remissions and as surveillance techniques to detect neoplasia improve, guidelines for surveillance will continue to evolve.

Original languageEnglish (US)
Article number16
JournalCurrent gastroenterology reports
Issue number9
StatePublished - Sep 2021


  • Colorectal cancer
  • Crohn’s disease
  • Epidemiology of colorectal cancer
  • Inflammatory bowel disease
  • Risk of colorectal cancer
  • Ulcerative colitis

ASJC Scopus subject areas

  • Gastroenterology


Dive into the research topics of 'Epidemiology of Colorectal Cancer in Inflammatory Bowel Disease – the Evolving Landscape'. Together they form a unique fingerprint.

Cite this